Positive T-Track® CMV Study Results With New Guidance Strategies For Anti-viral Treatment Decisions Following Stem Cell Transplantation
Lophius Biosciences GmbH today announced successful top-line results from its multicenter AlloProtect CMV clinical study. Results show the ability of Lophius’ CE-marked in vitro diagnostic test T-Track® CMV to transform treatment paradigms and patient management: in patients receiving an allogeneic Mehr







